202 related articles for article (PubMed ID: 38476610)
61. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
Dong X; Gu DN; Wang O; Ye Z
Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301
[TBL] [Abstract][Full Text] [Related]
62. Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway.
Di S; Gong M; Lv J; Yang Q; Sun Y; Tian Y; Qian C; Chen W; Zhou W; Dong K; Shi X; Wang Y; Wang H; Chu J; Gan S; Pan X; Cui X
Cancer Cell Int; 2023 Aug; 23(1):186. PubMed ID: 37649034
[TBL] [Abstract][Full Text] [Related]
63. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
[TBL] [Abstract][Full Text] [Related]
64. Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab.
Lyu C; Stadlbauer B; Wang L; Buchner A; Pohla H
Front Immunol; 2023; 14():1186388. PubMed ID: 37622107
[TBL] [Abstract][Full Text] [Related]
65. Extent and characteristics of immune infiltration in clear cell renal cell carcinoma and the prognostic value.
Wang Y; Yang J; Zhang Q; Xia J; Wang Z
Transl Androl Urol; 2019 Dec; 8(6):609-618. PubMed ID: 32038957
[TBL] [Abstract][Full Text] [Related]
66. The immune infiltration in clear cell Renal Cell Carcinoma and their clinical implications: A study based on TCGA and GEO databases.
Pan Q; Wang L; Chai S; Zhang H; Li B
J Cancer; 2020; 11(11):3207-3215. PubMed ID: 32231726
[TBL] [Abstract][Full Text] [Related]
67. Hepcidin as a prognostic biomarker in clear cell renal cell carcinoma.
Zhou Z; Wu J; Yang Y; Gao P; Wang L; Wu Z
Am J Cancer Res; 2022; 12(9):4120-4139. PubMed ID: 36225649
[TBL] [Abstract][Full Text] [Related]
68. Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients.
Xiong Y; Wang Z; Zhou Q; Zeng H; Zhang H; Liu Z; Huang Q; Wang J; Chang Y; Xia Y; Wang Y; Liu L; Zhu Y; Xu L; Dai B; Bai Q; Guo J; Xu J
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217761
[TBL] [Abstract][Full Text] [Related]
69. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J
Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993
[TBL] [Abstract][Full Text] [Related]
70. Protumorigenic Role of Elevated Levels of DNA Polymerase Epsilon Predicts an Immune-Suppressive Microenvironment in Clear Cell Renal Cell Carcinoma.
Wu X; Tang H; Xu WH; Tang H; Wei S; Anwaier A; Huang H; Qu YY; Zhang H; Zhao S; Li H; Liu W; Chen H; Ding C; Ye D
Front Genet; 2021; 12():751977. PubMed ID: 34950188
[TBL] [Abstract][Full Text] [Related]
71. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract][Full Text] [Related]
72. PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma.
Gan J; Zhang H
Transl Cancer Res; 2020 Aug; 9(8):4800-4810. PubMed ID: 35117843
[TBL] [Abstract][Full Text] [Related]
73. Bromodomain-containing protein 9 is a prognostic biomarker associated with immune infiltrates and promotes tumor malignancy through activating notch signaling pathway in negative HIF-2α clear cell renal cell carcinoma.
Lou W; Gao K; Xu C; Li Q
IUBMB Life; 2021 Nov; 73(11):1334-1347. PubMed ID: 34415102
[TBL] [Abstract][Full Text] [Related]
74. Development and implementation of a prognostic model for clear cell renal cell carcinoma based on heterogeneous TLR4 expression.
Zhou Q; Sun Q; Shen Q; Li X; Qian J
Heliyon; 2024 Feb; 10(4):e25571. PubMed ID: 38380017
[TBL] [Abstract][Full Text] [Related]
75. USP31 serves as a potential biomarker for predicting prognosis and immune responses for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing.
Yu Y; Chen G; Jiang C; Guo T; Tang H; Yuan Z; Wang Y; Tan X; Chen J; Zhang E; Wang X
J Gene Med; 2024 Jan; 26(1):e3594. PubMed ID: 37699648
[TBL] [Abstract][Full Text] [Related]
76. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
[TBL] [Abstract][Full Text] [Related]
77. Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Wang S; Chen S; Ying Y; Ma X; Shen H; Li J; Wang X; Lin Y; Liu B; Zheng X; Xie L
Front Cell Dev Biol; 2021; 9():676142. PubMed ID: 34291048
[TBL] [Abstract][Full Text] [Related]
78. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B
BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128
[TBL] [Abstract][Full Text] [Related]
79. Identification of candidate biomarker
Lv Q; Xiao W; Xiong Z; Shi J; Miao D; Meng X; Yuan H; Yang H; Zhang X
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1176-1190. PubMed ID: 34856762
[No Abstract] [Full Text] [Related]
80. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
Bian Z; Fan R; Xie L
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]